Chemomab Therapeutics Ltd. — Director's Dealing 2021

May 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-05-07

Reporting Person: Fatal Sigal (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-07	Option to Purchase American Depositary Shares	$27.26	A	35653	Acquired	2031-05-07	American Depositary Shares (35653)	Direct

Footnotes

F1: These options vest and become exercisable pursuant to the following schedule: 25% of the options shall vest on the first anniversary of November 7, 2020, and the remainder shall vest over three years in quarterly equal installments, subject to the Reporting Person's continued service.

F2: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.